Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207809849> ?p ?o ?g. }
- W3207809849 endingPage "1409" @default.
- W3207809849 startingPage "1397" @default.
- W3207809849 abstract "Renal impairment (RI) is common in patients with multiple myeloma (MM) and new therapies that can improve renal function are needed. The phase III IKEMA study (clinicaltrials gov. Identifier: NCT03275285) investigated isatuximab (Isa) with carfilzomib and dexamethasone (Kd) versus Kd in relapsed MM. This subgroup analysis examined results from patients with RI, defined as estimated glomerular filtration rate <60 mL/min/1.73 m². Addition of Isa prolonged progression-free survival (PFS) in patients with RI (hazard ratio: 0.27; 95% confidence interval [CI]: 0.11-0.66; median PFS not reached for Isa-Kd versus 13.4 months for Kd [20.8-month follow-up]). Complete renal responses occurred more frequently with Isa-Kd (52.0%) versus Kd (30.8%) and were durable in 32.0% versus 7.7% of patients, respectively. Treatment exposure was longer with Isa-Kd, with median number of started cycles and median duration of exposure of 20 versus 9 cycles and 81.0 versus 35.7 weeks for Isa-Kd versus Kd, respectively. Among patients with RI, the incidence of patients with grade ≥3 treatment-emergent adverse events was similar between the two arms (79.1% in Isa-Kd vs. 77.8% in Kd). In summary, the addition of Isa to Kd improved clinical outcomes with a manageable safety profile in patients with RI, consistent with the benefit observed in the overall IKEMA study population." @default.
- W3207809849 created "2021-10-25" @default.
- W3207809849 creator A5003468777 @default.
- W3207809849 creator A5004781025 @default.
- W3207809849 creator A5011827756 @default.
- W3207809849 creator A5012247336 @default.
- W3207809849 creator A5020996390 @default.
- W3207809849 creator A5034751203 @default.
- W3207809849 creator A5036747329 @default.
- W3207809849 creator A5042506692 @default.
- W3207809849 creator A5045917230 @default.
- W3207809849 creator A5048560248 @default.
- W3207809849 creator A5054343933 @default.
- W3207809849 creator A5054745393 @default.
- W3207809849 creator A5058270242 @default.
- W3207809849 creator A5077169512 @default.
- W3207809849 creator A5084017417 @default.
- W3207809849 date "2021-10-14" @default.
- W3207809849 modified "2023-10-17" @default.
- W3207809849 title "Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis" @default.
- W3207809849 cites W1920229793 @default.
- W3207809849 cites W1983533694 @default.
- W3207809849 cites W1987282802 @default.
- W3207809849 cites W1989803279 @default.
- W3207809849 cites W1994249743 @default.
- W3207809849 cites W1998723844 @default.
- W3207809849 cites W2003734726 @default.
- W3207809849 cites W2025348939 @default.
- W3207809849 cites W2038304921 @default.
- W3207809849 cites W2044392960 @default.
- W3207809849 cites W2055864845 @default.
- W3207809849 cites W2129126701 @default.
- W3207809849 cites W2141183397 @default.
- W3207809849 cites W2147731532 @default.
- W3207809849 cites W2191867422 @default.
- W3207809849 cites W2193716145 @default.
- W3207809849 cites W2277498048 @default.
- W3207809849 cites W2299833483 @default.
- W3207809849 cites W2319804562 @default.
- W3207809849 cites W2335826388 @default.
- W3207809849 cites W2409070542 @default.
- W3207809849 cites W2477107798 @default.
- W3207809849 cites W2486629951 @default.
- W3207809849 cites W2593723184 @default.
- W3207809849 cites W2613844594 @default.
- W3207809849 cites W2785647909 @default.
- W3207809849 cites W2795775889 @default.
- W3207809849 cites W2898240149 @default.
- W3207809849 cites W2902348661 @default.
- W3207809849 cites W2905394858 @default.
- W3207809849 cites W2949699542 @default.
- W3207809849 cites W2988984460 @default.
- W3207809849 cites W2990816134 @default.
- W3207809849 cites W2994110133 @default.
- W3207809849 cites W2995110787 @default.
- W3207809849 cites W3014627887 @default.
- W3207809849 cites W3015437056 @default.
- W3207809849 cites W3027520213 @default.
- W3207809849 cites W3096336916 @default.
- W3207809849 cites W3170038569 @default.
- W3207809849 doi "https://doi.org/10.3324/haematol.2021.279229" @default.
- W3207809849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34647444" @default.
- W3207809849 hasPublicationYear "2021" @default.
- W3207809849 type Work @default.
- W3207809849 sameAs 3207809849 @default.
- W3207809849 citedByCount "15" @default.
- W3207809849 countsByYear W32078098492021 @default.
- W3207809849 countsByYear W32078098492022 @default.
- W3207809849 countsByYear W32078098492023 @default.
- W3207809849 crossrefType "journal-article" @default.
- W3207809849 hasAuthorship W3207809849A5003468777 @default.
- W3207809849 hasAuthorship W3207809849A5004781025 @default.
- W3207809849 hasAuthorship W3207809849A5011827756 @default.
- W3207809849 hasAuthorship W3207809849A5012247336 @default.
- W3207809849 hasAuthorship W3207809849A5020996390 @default.
- W3207809849 hasAuthorship W3207809849A5034751203 @default.
- W3207809849 hasAuthorship W3207809849A5036747329 @default.
- W3207809849 hasAuthorship W3207809849A5042506692 @default.
- W3207809849 hasAuthorship W3207809849A5045917230 @default.
- W3207809849 hasAuthorship W3207809849A5048560248 @default.
- W3207809849 hasAuthorship W3207809849A5054343933 @default.
- W3207809849 hasAuthorship W3207809849A5054745393 @default.
- W3207809849 hasAuthorship W3207809849A5058270242 @default.
- W3207809849 hasAuthorship W3207809849A5077169512 @default.
- W3207809849 hasAuthorship W3207809849A5084017417 @default.
- W3207809849 hasBestOaLocation W32078098491 @default.
- W3207809849 hasConcept C126322002 @default.
- W3207809849 hasConcept C126894567 @default.
- W3207809849 hasConcept C159641895 @default.
- W3207809849 hasConcept C187960798 @default.
- W3207809849 hasConcept C197934379 @default.
- W3207809849 hasConcept C207103383 @default.
- W3207809849 hasConcept C2776063141 @default.
- W3207809849 hasConcept C2776364478 @default.
- W3207809849 hasConcept C2780108899 @default.
- W3207809849 hasConcept C2780306776 @default.
- W3207809849 hasConcept C2780401358 @default.
- W3207809849 hasConcept C2908647359 @default.